One of the MDLs is centered on gastrointestinal injuries associated with these drugs, while the other, smaller MDL is focused on NAION and vision loss
For those with diabetes, particularly type 2 diabetes, managing blood sugar levels is a daily concern
After this is completed, a maintenance phase is followed, consisting of 3-5g per day
Ozempic is approved for type 2 diabetes, but is sometimes used off-label for weight loss, and Wegovy is approved for weight loss, heart disease, and MASH
A comprehensive literature search across multiple databases identified a total of 6,541 studies, retrieved from PubMed ( n = 848), Web of Science ( n = 1,015), Scopus ( n = 2,523), Embase ( n = 1,525), Cochrane ( n = 367), as well as Google Scholar and manual reference searches ( n = 263)
Semaglutide Injections for Weight Loss Currently, semaglutide is only approved for weight loss under the brand name Wegovy